Unknown

Dataset Information

0

RAF1 deficiency causes a lethal syndrome that underscores RTK signaling during embryogenesis.


ABSTRACT: Somatic and germline gain-of-function point mutations in RAF, one of the first oncogenes to be discovered in humans, delineate a group of tumor-prone syndromes known as the RASopathies. In this study, we document the first human phenotype resulting from the germline loss-of-function of the proto-oncogene RAF1 (a.k.a. CRAF). In a consanguineous family, we uncovered a homozygous p.Thr543Met variant segregating with a neonatal lethal syndrome with cutaneous, craniofacial, cardiac, and limb anomalies. Structure-based prediction and functional tests using human knock-in cells showed that threonine 543 is essential to: (i) ensure RAF1's stability and phosphorylation, (ii) maintain its kinase activity toward substrates of the MAPK pathway, and (iii) protect from stress-induced apoptosis mediated by ASK1. In Xenopus embryos, mutant RAF1T543M failed to phenocopy the effects of normal and overactive FGF/MAPK signaling, confirming its hypomorphic activity. Collectively, our data disclose the genetic and molecular etiology of a novel lethal syndrome with progeroid features, highlighting the importance of RTK signaling for human development and homeostasis.

SUBMITTER: Wong S 

PROVIDER: S-EPMC10165362 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

RAF1 deficiency causes a lethal syndrome that underscores RTK signaling during embryogenesis.

Wong Samantha S   Tan Yu Xuan YX   Loh Abigail Yi Ting AYT   Tan Kiat Yi KY   Lee Hane H   Aziz Zainab Z   Nelson Stanley F SF   Özkan Engin E   Kayserili Hülya H   Escande-Beillard Nathalie N   Reversade Bruno B  

EMBO molecular medicine 20230417 5


Somatic and germline gain-of-function point mutations in RAF, one of the first oncogenes to be discovered in humans, delineate a group of tumor-prone syndromes known as the RASopathies. In this study, we document the first human phenotype resulting from the germline loss-of-function of the proto-oncogene RAF1 (a.k.a. CRAF). In a consanguineous family, we uncovered a homozygous p.Thr543Met variant segregating with a neonatal lethal syndrome with cutaneous, craniofacial, cardiac, and limb anomalie  ...[more]

Similar Datasets

| S-SCDT-10_15252-EMMM_202217078 | biostudies-other
| S-EPMC6428344 | biostudies-literature
| S-EPMC4508625 | biostudies-literature
| S-EPMC4579069 | biostudies-literature
| S-EPMC5548191 | biostudies-literature
| S-EPMC5458545 | biostudies-literature
| S-EPMC8155544 | biostudies-literature
| S-EPMC4311830 | biostudies-literature
| S-EPMC4819622 | biostudies-literature
| S-EPMC5477372 | biostudies-literature